XML 42 R29.htm IDEA: XBRL DOCUMENT v3.25.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Summary of Loss Before Income Taxes

Loss before income taxes are as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Losses before income taxes:

 

 

 

 

 

 

U.S.

 

$

(35,951

)

 

$

(116,736

)

Non-U.S.

 

 

198

 

 

 

199

 

Total

 

$

(35,753

)

 

$

(116,537

)

Summary of Provision for Income Taxes

The provision for income taxes are as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

Total current income tax provision

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

431

 

 

 

 

Foreign

 

 

 

 

 

 

Total deferred income tax provision

 

 

431

 

 

 

 

Total provision for income taxes

 

$

431

 

 

$

 

Reconciliation of U.S. Federal Statutory Income Tax Rate

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Statutory federal income tax rate

 

$

(7,508

)

 

$

(24,473

)

State income taxes, net of federal tax benefits

 

 

(908

)

 

 

(3,170

)

Tax credits

 

 

(2,358

)

 

 

(972

)

Stock-based compensation

 

 

2,819

 

 

 

728

 

Permanent items

 

 

12

 

 

 

9

 

Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds

 

 

(7,273

)

 

 

18,078

 

State rate differential

 

 

490

 

 

 

32

 

NOL true-up

 

 

(4

)

 

 

2

 

Other

 

 

24

 

 

 

566

 

Change in valuation allowance

 

 

15,137

 

 

 

9,200

 

Total provision for income taxes

 

$

431

 

 

$

 

Schedule of Significant Components Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2024 and 2023 consisted of the following (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Net operating loss carryforwards

 

$

22,740

 

 

$

18,089

 

Research and development tax credits

 

 

5,560

 

 

 

3,202

 

Accruals and reserves

 

 

366

 

 

 

475

 

Research expenditures

 

 

18,809

 

 

 

10,567

 

Stock-based compensation

 

 

3,281

 

 

 

3,085

 

Depreciation and amortization

 

 

1,056

 

 

 

1,319

 

Lease liability

 

 

225

 

 

 

91

 

Total deferred tax assets

 

 

52,037

 

 

 

36,828

 

Right-of-use asset

 

 

(218

)

 

 

(87

)

Acquired IPR&D

 

 

(7,623

)

 

 

(7,682

)

Total deferred tax liabilities

 

 

(7,841

)

 

 

(7,769

)

Less: valuation allowance

 

 

(46,379

)

 

 

(30,811

)

Net deferred tax liabilities

 

$

(2,183

)

 

$

(1,752

)

Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits

The following table reconciles the beginning and ending amounts of unrecognized tax benefits for the years presented (in thousands):

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Gross unrecognized tax benefits at the beginning of the year

 

$

3,636

 

 

$

2,664

 

Additions from tax positions taken in the current year

 

 

2,596

 

 

 

972

 

Additions from tax positions taken in prior years

 

 

 

 

 

 

Gross unrecognized tax benefits at the end of the year

 

$

6,232

 

 

$

3,636